Cargando…
Post-exposure prophylaxis for SIV revisited: Animal model for HIV prevention
BACKGROUND: A 4-week, uninterrupted treatment with 9-(2-phosphonyl-methoxypropyly)adenine (PMPA, commonly called tenofovir) completely prevents simian immunodeficiency virus (SIV(mne)) infection in cynomolgus macaques if treatment begins within 24 hours after SIV(mne )inoculation, but is less effect...
Autores principales: | Emau, Peter, Jiang, Yonghou, Agy, Michael B, Tian, Baoping, Bekele, Girma, Tsai, Che-Chung |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1687192/ https://www.ncbi.nlm.nih.gov/pubmed/17132170 http://dx.doi.org/10.1186/1742-6405-3-29 |
Ejemplares similares
-
RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models
por: Jiang, Yonghou, et al.
Publicado: (2009) -
Immunization by exposure to live virus (SIV(mne)/HIV-2(287)) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge
por: Frenkel, Lisa M., et al.
Publicado: (2021) -
Editorial: CD8+ T-cells in HIV/SIV infection, prophylaxis, and therapy
por: Shacklett, Barbara L., et al.
Publicado: (2023) -
Current perspectives in HIV post-exposure prophylaxis
por: Sultan, Binta, et al.
Publicado: (2014) -
Pre- and post-sexual exposure prophylaxis of HIV: An update
por: Marfatia, Yogesh S., et al.
Publicado: (2017)